RNA-targeting therapeutics

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

CAMP4 Therapeutics Issues Equity Award to New Employee Under Nasdaq Rules

CAMP4 Therapeutics granted 8,000 stock options to a new employee at $3.85/share exercise price, using standard four-year vesting under Nasdaq rules for talent attraction.
CAMPvesting scheduleemployee compensation